Essential Information for BioAge Investors
Levi & Korsinsky, LLP is reaching out to investors of BioAge Labs, Inc. (NASDAQ: BIOA) about an ongoing class action securities lawsuit. This communication aims to inform shareholders about their rights and give them opportunities to recover losses.
Understanding the Class Action Lawsuit
The class action lawsuit targets BioAge investors who experienced financial loss due to alleged securities fraud. It represents all shareholders who acquired shares in association with BioAge's initial public offering registration statement.
Details of the Case
According to the lawsuit, BioAge announced the discontinuation of its STRIDES Phase 2 trial for azelaprag, citing unexpected safety issues. This announcement was particularly shocking as BioAge previously highlighted the product's significance during its IPO presentation. Following this news, the value of BioAge's stock experienced a drastic drop, highlighting the potential financial implications for its investors.
What Investors Need to Know
If anyone sustained losses during the specified time frame due to the events described, they have until March 10, 2025, to request the Court appoint them as lead plaintiff. It’s essential to note that sharing in any potential recovery does not necessitate serving as the lead plaintiff.
No Fees Involved for Participants
For those participating in the class action, there is no out-of-pocket cost associated with getting involved. Investors can pursue their claims with the knowledge that there will be no financial obligation or risk on their part.
Why Choose Levi & Korsinsky?
Levi & Korsinsky has a long-standing reputation of securing significant recoveries for shareholders over the past two decades. Their expertise in complex securities litigation is backed by a specialized team committed to serving their clients. The firm ranks among the top 50 block firms nationwide, demonstrating a proven track record in this field.
Getting In Touch
For further assistance, investors can reach out to Joseph E. Levi, Esq. or Ed Korsinsky, Esq. at Levi & Korsinsky, LLP. They can provide detailed information regarding the lawsuit and answer any questions potential class members may have. The firm is located at 33 Whitehall Street, 17th Floor, New York, NY, and they can be contacted by phone for immediate assistance.
Frequently Asked Questions
What is the BioAge lawsuit about?
The lawsuit revolves around allegations of securities fraud impacting shareholders of BioAge Labs, Inc.
Who can participate in the class action?
Any shareholder of BioAge who incurred losses as defined by the lawsuit is eligible to participate.
What is the deadline to apply as a lead plaintiff?
The deadline to request lead plaintiff status is March 10, 2025.
Are there any costs to participate in this lawsuit?
No, there are no costs or obligations for class members to participate.
Why contact Levi & Korsinsky?
They have a strong track record of winning complex cases and are dedicated to protecting shareholder interests.
